The Leukemia & Lymphoma Society of Canada and the Canadian MPN Network have been working alongside clinicians, pharmaceutical manufacturers and Health Canada to find a solution for Canadians who are impacted by myeloproliferative neoplasms (MPN ..read more

To further extend their collaboration, raise awareness on blood cancers, and to formalize their commitment to their partnership, the CANO and The Leukemia & Lymphoma Society of Canada (LLSC) have signed a memorandum of understanding (MOU) represented by Pascale Rousseau, LLSC Community Programs Manager, and Lorelei Newton, CANO President for 2023/24 ..read more

Christina Sit of The Leukemia & Lymphoma Society of Canada, and a co-chair of Cancer Action Now alliance, speaks with CityNews Toronto reporter about why she and other patient advocacy groups and cancer survivors are at Queen's Park on Nov 18, 2024 to "Line up for change" in cancer care ..read more

The Leukemia & Lymphoma Society of Canada, with partners like The Collings Stevens Family Foundation, is informing and empowering people impacted by chronic myeloid leukemia (CML), a once-fatal blood cancer now a manageable disease ..read more

Graft vs. Host Disease (GvHD) is a serious side effect that commonly affects people who've undergone an allogeneic stem cell transplant (SCT), meaning they've received stem cells to treat their blood cancer. LLSC presented at the International GvHD Symposium in October 2024 in Vancouver on this significant health challenge, and released a podcast episode about GvHD, and other new resources ..read more

Mental health challenges such as depression, anxiety and PTSD, can exist in blood cancer survivors and their caregivers even years after treatment is over ..read more

Life after cancer looks different for every individual, including a return to work - if that is even possible ..read more

A new research project, funded by a LLSC Blood Cancer Quality of Life Grant, will investigate the blood cancer experience of South Asian Canadians over the age of 65 and their caregivers ..read more

One of the exciting, novel aspects of LLSC’s latest blood cancer research awards is the introduction of the Artificial Intelligence (AI) Catalyst Grant, for the application of AI to blood cancer research ..read more

Until September 1, Skincare innovator La Roche-Posay will match your gift and double its value, up to $50,000 ..read more